Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 3—March 2006

Cost-effectiveness of West Nile Virus Vaccination

Armineh Zohrabian*Comments to Author , Edward B. Hayes†, and Lyle R. Petersen†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Centers for Disease Control and Prevention, Fort Collins, Colorado, USA

Main Article

Table 2

Outcome distributions of average cost-effectiveness ratio (ACER) accounting for variability in all input variables*

Statistic ACER†
5th–95th percentile range, $ –59,000 to –20,000
Mean, $ –36,000
Median, $ –35,000
Mode, $ –33,000
Probability of savings, % 0

*According to the distribution provided in Table 1.
†Negative value indicates cost.

Main Article

Page created: January 27, 2012
Page updated: January 27, 2012
Page reviewed: January 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.